✦ LIBER ✦

Pharmacokinetics of sparfloxacin in patients with renal impairment

✍ Scribed by Mary Beth Dorr; Robert D. Johnson; Bradford Jensen; David Magner; Thomas Marbury; George H. Talbot

Book ID: 117320851
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 922 KB
Volume: 21
Category: Article
ISSN: 0149-2918
DOI: 10.1016/s0149-2918(00)80023-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of atenolol in patients

Pharmacokinetics of atenolol in patients with renal impairment

✍ J. Sassard; N. Pozet; J. McAinsh; J. Legheand; P. Zech 📂 Article 📅 1977 🏛 Springer 🌐 English ⚖ 660 KB

Pharmacokinetics of quinolones in patien

Pharmacokinetics of quinolones in patients with renal impairment

✍ J.-P. Fillastre; A. Leroy; B. Moulin; M. Dhib; G. Humbert 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 230 KB

Pharmacokinetics of glimepiride in patie

Pharmacokinetics of glimepiride in patients with renal impairment

📂 Article 📅 1997 🏛 Adis International Limited (now part of Wolters Kl ⚖ 332 KB

Insulin Degludec: Pharmacokinetics in Pa

Insulin Degludec: Pharmacokinetics in Patients with Renal Impairment

✍ Kiss, István; Arold, Gerhard; Roepstorff, Carsten; Bøttcher, Susanne Gammelgaard 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 377 KB

Pharmacokinetics of cefadroxil in patien

Pharmacokinetics of cefadroxil in patients with terminal renal impairment

✍ Mariño, E.L.; Dominguez-Gil, A.; Tabernero, J.M.; Rubio, F. 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 712 KB

Pharmacokinetics of carteolol in patient

Pharmacokinetics of carteolol in patients with impaired renal function

✍ M. Amemiya; K. Tabei; H. Furuya; Y. Sakairi; Y. Asano 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 503 KB